Transforming growth factor β neutralization ameliorates pre-existing hepatic fibrosis and reduces cholangiocarcinoma in thioacetamide-treated rats - Wikidata - awgldk - TriplyDB

Transforming growth factor β neutralization ameliorates pre-existing hepatic fibrosis and reduces cholangiocarcinoma in thioacetamide-treated rats

Transforming growth factor β neutralization ameliorates pre-existing hepatic fibrosis and reduces cholangiocarcinoma in thioacetamide-treated rats

http://www.wikidata.org/entity/Q34563199

about

Promising Therapy Candidates for Liver Fibrosis Targeted therapy in biliary tract cancers-current limitations and potentials in the future.Inhibitory effect of liposomal quercetin on acute hepatitis and hepatic fibrosis induced by concanavalin A Cholangiocarcinoma: molecular pathways and therapeutic opportunities Attenuation of CCl4-induced hepatic fibrosis in mice by vaccinating against TGF-β1 The expression of HIV-1 Vpu in monocytes causes increased secretion of TGF-β that activates profibrogenic genes in hepatic stellate cells.Treatment of cholestatic fibrosis by altering gene expression of Cthrc1: Implications for autoimmune and non-autoimmune liver disease.A network pharmacology approach to discover active compounds and action mechanisms of San-Cao Granule for treatment of liver fibrosis Desmoplastic stroma and cholangiocarcinoma: clinical implications and therapeutic targeting.Molecular mechanism of cholangiocarcinoma carcinogenesis.Delivery and targeting of miRNAs for treating liver fibrosis.New therapies for hepatic fibrosis.New Developments on the Treatment of Liver Fibrosis.WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited.Liver inflammation and fibrosis.Transforming growth factor-β: A therapeutic target for cancer.A Selective Transforming Growth Factor-β Ligand Trap Attenuates Pulmonary Hypertension.Transforming Growth Factors α and β Are Essential for Modeling Cholangiocarcinoma Desmoplasia and Progression in a Three-Dimensional Organotypic Culture Model.Arkadia protein expression is reduced in the liver during the progression of hepatic fibrosis.The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer.Mating decreases plasma levels of TGFβ1 and regulates myosalpinx expression of TGFβ1/TGFBR3 in the rat.The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium

P2860

Q26766727-628011E1-8C38-426A-BAA7-81723F6DAB28 Q30234532-E01EFF35-5029-442A-9369-B72F220E25C9 Q34193125-481DE6BB-5100-4A5A-8D9A-85C23F33AFF2 Q34959174-EFB70826-2B08-4857-9F02-AF6A07655F26 Q35070050-2C905041-CD01-407A-8FF0-14F6160EA3B2 Q35097640-189C778C-998C-4089-AFA9-D7DC7FBD841E Q36279532-4F64DCDE-44E6-4DF5-9B99-F0C01633CFAD Q36617742-0BC352AB-D4FC-4A58-BB1A-4CC5FA7D5D83 Q38152382-BD3DA920-4EA5-433F-A2A5-8F1B28609A51 Q38217475-827BD121-D406-4CD5-B591-09B6E0E9F9B8 Q38245905-A101A65A-79C4-44B4-9A0A-AB7793FB07E3 Q38553309-F614D5D2-4B91-4FCE-A114-505FE93E4F58 Q38873303-84E2CB4B-0F24-4B60-A873-0B34F03E5A24 Q38908764-A64384F7-8884-4E44-A01E-E28B7FEF020B Q39065620-B70E508E-EC1E-4878-A330-8F4EACB6A293 Q39346505-A1F70E51-9974-41CB-B851-B8218B0E6007 Q42752955-2EB07124-6646-47DC-AC27-80412572E697 Q45055057-6E0696B2-75E4-401C-9BD0-28F895473E3E Q47235548-D54A4316-02C3-499A-9692-EF0D3E5F78A4 Q50350640-7E0BF508-86C3-40D7-AF47-2E4DBF93F1E1 Q54186835-DC58E330-1EE3-46A1-A4AD-142B68E46604 Q59133892-02879D1C-E902-41EA-9C39-6473EB576CC2

P2860

Transforming growth factor β neutralization ameliorates pre-existing hepatic fibrosis and reduces cholangiocarcinoma in thioacetamide-treated rats

http://www.wikidata.org/entity/Q34563199

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

name

Transforming growth factor β n ...... in thioacetamide-treated rats

@ast

Transforming growth factor β n ...... in thioacetamide-treated rats

@en

Transforming growth factor β n ...... in thioacetamide-treated rats

@nl

type

label

Transforming growth factor β n ...... in thioacetamide-treated rats

@ast

Transforming growth factor β n ...... in thioacetamide-treated rats

@en

Transforming growth factor β n ...... in thioacetamide-treated rats

@nl

prefLabel

Transforming growth factor β n ...... in thioacetamide-treated rats

@ast

Transforming growth factor β n ...... in thioacetamide-treated rats

@en

Transforming growth factor β n ...... in thioacetamide-treated rats

@nl

P1433

Q34563199-A98BDF4F-227B-4CA3-841A-D4505BA64855

P1476

Q34563199-A69D6A3D-F400-4EED-8A41-4144735C6F44

P2093

Q34563199-11509CAE-5F5F-4075-9A5D-BB0A42B67B74

Q34563199-1CA6295F-78C1-489E-B63A-029CF963FD34

Q34563199-3342108E-4B58-4074-A7B9-F474FC17FC3C

Q34563199-7B03B781-63B0-44A4-B288-72ED728E1C36

Q34563199-89BC1A30-F819-4E19-9399-6FF859D36DB5

Q34563199-903D9B51-EFF4-4E8D-95D7-31681F6840CD

Q34563199-B75E88D3-D677-4B97-86B2-B9D4AE69E68D

Q34563199-BA91F797-67A1-44BA-BE73-837135FB31E7

Q34563199-BFC401C1-6639-4504-87D7-706FA6C0B25F

P2860

Q34563199-031EFB3F-E431-471C-A585-E23061492510

Q34563199-035D2E23-8281-4CC8-A743-CE386D0B9740

Q34563199-05701633-4918-4EC6-AA5B-8A273564819D

Q34563199-2951F0D6-DEBE-491B-AF85-44C30B8290C9

Q34563199-2E041995-FB25-4C29-B14A-ECBD80FFC91C

Q34563199-2EC3B0F8-263B-45E3-9B12-B608534357D1

Q34563199-3FF386D5-37E6-42E1-A5DC-C2A430F7E015

Q34563199-4217E849-6488-466F-8B7D-A5413717CAF8

Q34563199-5F60B583-FB62-4D59-B974-A4C9803196E5

Q34563199-5F755C99-1C5D-48D2-BCB3-0BFE5337F025

P304

Q34563199-AE205002-A8DA-4848-ABFB-D7592E9CDC06

P31

Q34563199-C7ADFBCB-7E27-41F8-AF41-16A364FCA32A

P356

Q34563199-6818A79E-7014-44EA-9FCC-56B1CAAE6D9E

P407

Q34563199-62DF277A-BFD9-4D26-99E2-CAFC699C277C

P433

Q34563199-DA3BB2BD-84DA-4798-94F7-9FA3F23CBF64

P478

Q34563199-B3130A97-7723-4258-B287-78CB84D8C247

P577

Q34563199-1DFF6DB4-107E-4D6A-869C-587F1E571FBF

P5875

Q34563199-F70BAD65-4CDF-4F68-90D1-AA2ECF64FBC7

P698

Q34563199-C179A48E-2A8E-4263-9304-119B0495BC3C

P921

Q34563199-611E92F4-41E3-4E36-B96D-9B236C13D9B3

P932

Q34563199-8B845EA8-98AA-4C6D-A171-06B4A65BEEDB

P356

JOURNAL.PONE.0054499

P1433

P1476

Transforming growth factor β n ...... in thioacetamide-treated rats

@en

P2093

Anna Zuk

http://www.w3.org/2001/XMLSchema#string

Cynthia Arbeeny

http://www.w3.org/2001/XMLSchema#string

Donna Hempel

http://www.w3.org/2001/XMLSchema#string

Eric Roux

http://www.w3.org/2001/XMLSchema#string

Hong Ling

http://www.w3.org/2001/XMLSchema#string

Jingzang Tao

http://www.w3.org/2001/XMLSchema#string

Mandy Smith

http://www.w3.org/2001/XMLSchema#string

Scott Lonning

http://www.w3.org/2001/XMLSchema#string

Steve Ledbetter

http://www.w3.org/2001/XMLSchema#string

P2860

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets

Adenoviral delivery of dominant-negative transforming growth factor beta type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in rats

TGF-beta signaling in tumor suppression and cancer progression

Stromal fibroblasts in cancer initiation and progression

Mechanisms of hepatic fibrogenesis

Hepatic fibrosis.

Chronic liver injury, TGF-beta, and cancer.

TGF beta signalling and its role in tumour pathogenesis.

P304

e54499

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0054499

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235372266

http://www.w3.org/2001/XMLSchema#string

P698

23349909

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

P932

3547926

http://www.w3.org/2001/XMLSchema#string